A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia-Reference-Cited by-同舟云学术

A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia

Published:1998-06 Issue:11 Volume:43 Page:803-810
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Tollefson Gary D.,Sanger Todd M.,Beasley Charles M.,Tran Pierre V.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference53 articles.

1. A rating scale for drug-induced akathisia;Barnes;Br J Psychiatry,1980

2. Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial;Beasley;Neuropsychopharmacology,1996

3. Depression in schizophrenia;Becker;Hosp Community Psychiatry,1988

4. Depression, demoralization and control over psychotic illness;Birchwood;Psychol Med,1993

5. Suicide in schizophrenia;Black;J Clin Psychiatry,1985

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysis;Schizophrenia Research;2024-08

2. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

3. Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study;Therapeutic Drug Monitoring;2023-03-14

4. Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials;Clinical Psychopharmacology and Neuroscience;2022-11-30

5. Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data;Journal of Clinical Psychopharmacology;2022-10-25